Down-regulation of Mus81 as a potential marker for the malignancy of gastric cancer

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5011-5014

  Wu, Fan ^a,b   Shirahata, Atsushi ^b   Sakuraba, Kazuma ^b   Kitamura, Yohei ^b   Goto, Tetsuhiro ^b   Saito, Mitsuo ^b   Ishibashi, Kazuyoshi ^b   Kigawa, Gaku ^b   Nemoto, Hiroshi ^b   Sanada, Yutaka ^b   Hibi, Kenji ^b  

^a GUANGZHOU RED CROSS HOSPITAL   (China)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Gastric cancer; Mus81

Indexed keywords

ADULT; AGED; ARTICLE; CANCER TISSUE; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MUS81 GENE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOMA;

AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; DOWN-REGULATION; ENDONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78751499342     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999.
3. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35: 111-115, 2000.
4. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K and Nakao A: Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci 97: 395-399, 2006.
5. Hibi K, Sakata M, Sakuraba K, Kitamura YH, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Methylation of the DCC gene is lost in advanced gastric cancer. Anticancer Res 30: 107-109, 2010.
6. Sakata M, Kitamura YH, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: Methylation of HACE1 in gastric carcinoma. Anticancer Res 29: 2231-2233, 2009.
7. Hibi K, Sakata M, Yokomizo K, Kitamura YH, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma. Anticancer Res 29: 5053-5055, 2009.
8. Jankowski JA and Odze RD: Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 104: 1093-1096, 2009.
9. Interthal H and Heyer WD: MUS81 encodes a novel helixhairpin-helix protein involved in the response to UV- and methylation-induced DNA damage in Saccharomyces cerevisiae. Mol Gen Genet 263: 812-827, 2000.
10. Chang JH, Kim JJ, Choi JM, Lee JH and Cho Y: Crystal structure of the Mus81- Eme 1 complex. Genes Dev 22: 1093-1106, 2008.
11. Dendouga N, Gao H, Moechars D, Janicot M, Vialard J and McGowan CH: Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis. Mol Cell Biol 25: 7569-7579, 2005.
12. McPherson JP, Lemmers B, Chahwan R, Pamidi A, Migon E, Matysiak-Zablocki E, Moynahan ME, Essers J, Hanada K, Poonepalli A, Sanchez-Sweatman O, Khokha R, Kanaar R, Jasin M, Hande MP and Hakem R: Involvement of mammalian Mus81 in genome integrity and tumor suppression. Science 304: 1822-1826,2004.
13. Pamidi A, Cardoso R, Hakem A, Matysiak-Zablocki E, Poonepalli A, Tamblyn L, Perez-Ordonez B, Hande MP, Sanchez O and Hakem R: Functional interplay of p53 and Mus81 in DNA damage responses and cancer. Cancer Res 67: 8527-8535, 2007.
14. Willis N and Rhind N: Mus81, Rhp51 (Rad51), and Rqh1 form an epistatic pathway required for the S-phase DNA damage checkpoint. Mol Biol Cell 20: 819-833, 2009.
15. Zeng S, Xiang T, Pandita TK, Gonzalez-Suarez I, Gonzalo S, Harris CC and Yang Q: Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol 11: 616-623, 2009.
16. Loizidou MA, Cariolou MA, Neuhausen SL, Newbold RF, Bashiardes E, Marcou Y, Michael T, Daniel M, Kakouri E, Papadopoulos P, Malas S, Hadjisavvas A and Kyriacou K: Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population. Breast Cancer Res Treat 121: 147-156, 2010.
17. Jiang Z, Hu J, Li X, Jiang Y, Zhou W and Lu D: Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array. Neurosci Lett 409: 112-117, 2006.
18. Wu F, Liu SY, Tao YM, Ou DP, Fang F and Yang LY: Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma. Cancer 112: 2002-2010, 2008.
19. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996.
20. Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H and Takahashi T: Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6: 2291-2296, 1991.
21. LLeonart ME, Vidal F, Gallardo D, Diaz-Fuertes M, Rojo F, Cuatrecasas M, López-Vicente L, Kondoh H, Blanco C, Carnero A and Ramón y Cajal S: New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. Oncol Rep 16: 603-608, 2006.
22. Hegi ME, Sciuscio D, Murat A, Levivier M and Stupp R: Epigenetic deregulation of DNA repair and its potential for therapy. Clin Cancer Res 15: 5026-5031, 2009.
23. Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R and Cascinu S: Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev 30: 451-459, 2004. (Pubitemid 38968125)
24. Nitti D, Mocellin S, Marchet A, Pilati P and Lise M: Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 17: 467-483, 2008. (Pubitemid 351672072)